GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

Ratios of visceral proteins can act as independent indicators for both overall and progression-free survival in patients with ...

Patients in the induction chemotherapy group reported more frequent grade 3 or greater adverse events. Evidence Rating Level: ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

The INAVO120 study reveals that the three-drug therapy inavolisib, palbociclib and fulvestrant significantly delays cancer ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

The FDA recently approved the combination of inavolisib, fulvestrant, and palbociclib in this patient population.

THURSDAY, Oct. 31, 2024 (HealthDay News) -- Inavolisib plus palbociclib-fulvestrant yields significantly longer ...